Year: 2022
-
Northwestern Awarded First-Ever National Grant to Study Wearables, Stroke Prevention in Patients With Atrial Fibrillation
Northwestern University has been awarded a seven-year grant to study a “pill-in-pocket” strategy to prevent stroke in patients with atrial fibrillation, the most common heart rhythm disorder in adults.
-
Coming Wave of Opioid Overdoses ‘Will be Worse Than Ever Been Before’
Geography played a role in opioid-involved overdose deaths in the past, but a coming wave may discriminate between rural and urban areas, according to a recent study.
-
Investigating the Role of Dopamine Circuits in Habit Formation
Scientists have uncovered how dopamine connects subregions of the striatum essential for habit formation, according to a Northwestern Medicine study.
-
Protein Transformation Drives Cancer Development
A change in function in a mitochondrial protein is associated with gene expression that may promote the development of cancer, according to a recent Northwestern Medicine Study.
-
Northwestern Launches New Center for Human Immunobiology
In the newly formed Center for Human Immunobiology, teams of interdisciplinary scientists and clinicians will work together to understand the immune system at the molecular level and translate new discoveries into cures for immune-regulated diseases.
-
Diabetes Drug Metformin Shows Potential Benefit in Large COVID-19 Trial
Metformin, a common, safe and inexpensive drug for type 2 diabetes, lowered the odds of emergency department visits, hospitalizations or death due to COVID-19 by over 40 percent, according to a new multi-site clinical trial.
-
Novel Telehealth Strategy Will Treat Three Cancer Risk Behaviors at Once
A new Northwestern Medicine trial will test whether a telehealth-based intervention that addresses three behavioral risk factors at once can modify cancer patients’ lifestyles to improve their outcomes.
-
Bigger is Better for Genetic Tests That Check for Cardiomyopathy, Arrhythmias
Bigger test panels are better for genetic testing in cardiomyopathy and heart arrhythmias, according to a recent Northwestern Medicine study.
-
Inflammatory Signaling Linked to Leukemia Progression
An inflammatory signaling protein called interleukin-6 has been linked to the progression of acute myeloid leukemia, representing a potential target for future treatments of the disease.
-
Emerging Therapy for Relapsed Lymphoma
An emerging therapy showed promise in patients with relapsed B-cell lymphoma who are not ideal candidates for stem cell transplants.
